Century Therapeutics
IPSC
67 hedge funds and large institutions have $96.6M invested in Century Therapeutics in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 10 closing their positions.
4,300% more call options, than puts
Call options by funds: $44K | Put options by funds: $1K
62% more capital invested
Capital invested by funds: $59.6M → $96.6M (+$37M)
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
6% more funds holding
Funds holding: 63 → 67 (+4)
5.65% more ownership
Funds ownership: 30.01% → 35.66% (+5.7%)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
+$14.4M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$7.41M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
+$2.29M |
| 4 |
Millennium Management
New York
|
+$925K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$817K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.46M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$704K |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$565K |
| 5 |
NYLIM
New York Life Investment Management
New York
|
-$332K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$8 | +2 | New |
|
IPSC Hedge Fund Activity: Q1 2024 in Review
67 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q1 2024, worth a combined $96.6M — up 62% from $59.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IPSC positions and 10 closed out — a net gain of 4 holders — while 16 added to existing stakes and 22 trimmed.
The largest buyer was VR Adviser, opening a new position worth an estimated $14.4M. The largest seller was Morgan Stanley, cutting an estimated $1.46M.
- 67 institutional investors held Century Therapeutics (IPSC) as of Q1 2024, up from 63 in Q4 2023.
- Funds reported $96.6M of Century Therapeutics stock for Q1 2024, up 62% quarter-over-quarter.
- 14 funds opened new Century Therapeutics positions in Q1 2024 and 10 closed out, a net change of +4 holders.
- The largest Century Therapeutics buyer in Q1 2024 was VR Adviser, an estimated $14.4M added.
- The largest Century Therapeutics seller in Q1 2024 was Morgan Stanley, an estimated $1.46M sold.
Based on aggregated 13F filings for Q1 2024.